Microscale culture of human liver cells for drug development
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tissue function depends on hierarchical structures extending from single cells ( approximately 10 microm) to functional subunits (100 microm-1 mm) that coordinate organ functions. Conventional cell culture disperses tissues into single cells while neglecting higher-order processes. The application of semiconductor-driven microtechnology in the biomedical arena now allows fabrication of microscale tissue subunits that may be functionally improved and have the advantages of miniaturization. Here we present a miniaturized, multiwell culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks. The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicity. We demonstrate utility through assessment of gene expression profiles, phase I/II metabolism, canalicular transport, secretion of liver-specific products and susceptibility to hepatotoxins. The combination of microtechnology and tissue engineering may enable development of integrated tissue models in the so-called 'human on a chip'.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, hepatic models that utilize conventional 2D mono-and co-cultures of normal and diseased human cells fail to mimic the complex threedimensional (3D) in vivo microenvironment and extracellular matrix (ECM) support [16,19,20].”
From A liver-on-a-chip platform with bioprinted hepatic spheroids (2016) · cites this paper as [16]
In the citing paper
“The oxygenated or microfabricated co-cultures have been reported to allow HHs to retain metabolic function for a few weeks; however, these cells lose their proliferative capacity (Khetani and Bhatia, 2008; Kidambi et al., 2009”
From In Vitro Expansion of Primary Human Hepatocytes with Efficient Liver Repopulation Capacity (2018) · cites this paper as Khetani and Bhatia, 2008
Citations
Cites
Geometric Control of Cell Life and Death
Chen, C. S., Mrksich, M., Huang, S., Whitesides, G. M., & Ingber, D. E. (1997) · Science · doi:10.1126/science.276.5317.1425 · Cited by 4,657 · cited 1×
“Over the last decade, microtechnology tools have emerged to probe biomedical phenomena at relevant length scales and to miniaturize and parallelize biomedical assay”
BackgroundRheinwatd, J. G., & Green, H. (1975) · Cell · doi:10.1016/s0092-8674(75)80001-8 · Cited by 4,537
Soft Lithography in Biology and Biochemistry
Whitesides, G. M., Ostuni, E., Takayama, S., Jiang, X., & Ingber, D. E. (2001) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.3.1.335 · Cited by 2,607 · cited 1×
“Our approach incorporates 'soft lithography' techniques, using reusable, elastomeric molds of microfabricated structures to overcome limitations of photolithograph”
MethodIdiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054 · cited 1×
“The need for such models is underscored by the high rate of pre-launch and post-market attrition of pharmaceuticals due to liver toxicit”
BackgroundGenome-wide expression monitoring in Saccharomyces cerevisiae
Wodicka, L., Dong, H., Mittmann, M., Ho, M.-H., & Lockhart, D. J. (1997) · Nature Biotechnology · doi:10.1038/nbt1297-1359 · Cited by 973
Bhatia, S. N., Balis, U. J., Yarmush, M. L., & Toner, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.1883 · Cited by 890
Self-citationWilkening, S., Stahl, F., & Bader, A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.8.1035 · Cited by 794 · cited 1×
“Although hepatocarcinoma-derived cell lines and immortalized hepatocytes can be reproducible and inexpensive, they display abnormal levels of liver-specific function”
BackgroundHewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., et al. (2007) · Drug Metabolism Reviews · doi:10.1080/03602530601093489 · Cited by 735
Newton, D. J., Wang, R. W., & Lu, A. Y. (1995) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)06500-6 · Cited by 605
LeCluyse, E. L. (2001) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00135-x · Cited by 477
Cited by
Items 201–300 of 1,000
Cells Cultured on Core–Shell Photonic Crystal Barcodes for Drug Screening
Fu, F., Shang, L., Zheng, F., Chen, Z., Wang, H., Wang, J., Gu, Z., & Zhao, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04966 · Cited by 118
Human biomimetic liver microphysiology systems in drug development and precision medicine
Gough, A., Soto-Gutierrez, A., Vernetti, L., Ebrahimkhani, M. R., Stern, A. M., & Taylor, D. L. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00386-1 · Cited by 117
Long-Term Culture and Coculture of Primary Rat and Human Hepatocytes
Shulman, M., & Nahmias, Y. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-62703-125-7_17 · Cited by 117
“Cell morphology and gene expression were preserved for 4–6 weeks (28).”
BackgroundMaterne, E.-M., Tonevitsky, A. G., & Marx, U. (2013) · Lab on a Chip · doi:10.1039/c3lc50240f · Cited by 112
High-Content Drug Screening with Engineered Musculoskeletal Tissues
Vandenburgh, H. (2010) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2009.0445 · Cited by 105
Tissue Engineering in Liver Regenerative Medicine: Insights into Novel Translational Technologies
Heydari, Z., Najimi, M., Mirzaei, H., Shpichka, A. I., Ruoß, M., Farzaneh, Z., Montazeri, L., Piryaei, A., Timashev, P. S., Gramignoli, R., et al. (2020) · Cells · doi:10.3390/cells9020304 · Cited by 117
Badr-Eldin, S. M., Aldawsari, H. M., Kotta, S., Deb, P. K., & Venugopala, K. N. (2022) · Pharmaceuticals · doi:10.3390/ph15080926 · Cited by 118
“A liver-on-chip model was built to study pharmacokinetic parameters, hepatotoxicity [104], and phase I/II metabolism of drug molecules [105].”
BackgroundMethodInvestigation of ifosfamide nephrotoxicity induced in a liver–kidney co‐culture biochip
Choucha‐Snouber, L., Aninat, C., Grsicom, L., Madalinski, G., Brochot, C., Poleni, P. E., Razan, F., Guillouzo, C. G., Legallais, C., Corlu, A., et al. (2013) · Biotechnology and Bioengineering · doi:10.1002/bit.24707 · Cited by 109
“…the interactions between homogenous co-cultures of one specific cell type, or between two or more cell types and thus lead to new additional and specific relevant information concerning tissue differentiation and functionality (Bhatia et al., 1997; Corlu et al., 1991; Khetani and Bhatia, 2008).”
BackgroundMicroengineered Liver Tissues for Drug Testing
Khetani, S. R., Berger, D. R., Ballinger, K. R., Davidson, M. D., Lin, C., & Ware, B. R. (2015) · SLAS Technology · doi:10.1177/2211068214566939 · Cited by 116
“In particular, PDMS stencils were initially used to pattern ECM, and then a PDMS gasket was used to provide 24 distinct wells for drug dosing over the MPCCs.74 However, since PDMS is a porous and hydrophobic material, drugs and other hydrophobic molecules in culture medium (i.e., proteins) had a tendency to get soaked…”
BackgroundMethodInfluentialSelf-citationKratochwil, N. A., Meille, C., Fowler, S., Klammers, F., Ekiciler, A., Molitor, B., Simon, S., Walter, I., McGinnis, C., Walther, J., et al. (2017) · The AAPS Journal · doi:10.1208/s12248-016-0019-7 · Cited by 109
Microfluidic devices for in vitro studies on liver drug metabolism and toxicity
van Midwoud, P. M., Verpoorte, E., & Groothuis, G. M. M. (2011) · Integrative Biology · doi:10.1039/c0ib00119h · Cited by 115
Liver-Based In Vitro Technologies for Drug Biotransformation Studies - A Review
Fasinu, P. S., Bouic, P. J., & Rosenkranz, B. (2012) · Current Drug Metabolism · doi:10.2174/138920012798918426 · Cited by 115
Hegde, M., Jindal, R., Bhushan, A., Bale, S. S., McCarty, W. J., Golberg, I., Usta, O. B., & Yarmush, M. L. (2014) · Lab Chip · doi:10.1039/c4lc00071d · Cited by 104
Park, K.-M., Hussein, K. H., Hong, S.-H., Ahn, C., Yang, S.-R., Park, S.-M., Kweon, O.-K., Kim, B.-M., & Woo, H.-M. (2016) · Tissue Engineering Part A · doi:10.1089/ten.tea.2015.0313 · Cited by 113
“49,50 Similar to the primary cells, iPSC-Heps also have limited capacity for long-term survival and proliferation.”
Gao, Y., Majumdar, D., Jovanovic, B., Shaifer, C., Lin, P. C., Zijlstra, A., Webb, D. J., & Li, D. (2011) · Biomedical Microdevices · doi:10.1007/s10544-011-9523-9 · Cited by 103
“One popular microfluidic co-culture technique is surface patterning (Bhatia et al. 1997; Kane et al. 2006; Khetani and Bhatia 2008), which relies on modification of the substrate surface by attaching desired molecules in predetermined patterns.”
BackgroundThe potential of induced pluripotent stem cell derived hepatocytes
Hannoun, Z., Steichen, C., Dianat, N., Weber, A., & Dubart‐Kupperschmitt, A. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.025 · Cited by 113
“Many 2D cultures use combinations of primary hepatocytes and other cell types such as; fibroblasts [132, 133], liver sinusoidal endothelial cells (LSECs) [134], stellate cells [135], Kupffer cells [136] and”
BackgroundStem cell-derived polarized hepatocytes
Thi, V. L. D., Wu, X., Belote, R. L., Andréo, U., Takacs, C. N., Fernandez, J., Vale-Silva, L. A., Prallet, S., Decker, C. C., Fu, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15337-2 · Cited by 112
Hill, A., Mesens, N., Steemans, M., Xu, J. J., & Aleo, M. D. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2011.645578 · Cited by 111
“Screening on hepatocellular systems that hold normal physiology of hepatocytes better, such as liver stem cells (Hay et al., 2011) and the three-dimensional liver culture (Khetani and Bhatia, 2008), is under investigation and will likely be integrated in the screening process in the future.”
BackgroundWare, B. R., Durham, M. J., Monckton, C. P., & Khetani, S. R. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.11.007 · Cited by 103
“Furthermore, 3T3-J2 fibroblasts have a lack of detectable liver functions, display contact inhibition that avoids overgrowth, and are propagated easily before inclusion in coculture.(12,16,28,51) More importantly, the use of 3T3-J2 fibroblasts in coculture with PHHs does not prevent”
BackgroundMethodResultSelf-citationA review on the application, simulation, and experiment of the electrokinetic mixers
Rashidi, S., Bafekr, H., Valipour, M. S., & Esfahani, J. A. (2018) · Chemical Engineering and Processing - Process Intensification · doi:10.1016/j.cep.2018.02.021 · Cited by 110
Droplet-Based Microfluidics: Enabling Impact on Drug Discovery
Dressler, O. J., Maceiczyk, R. M., Chang, S., & deMello, A. J. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113510401 · Cited by 110
Fowler, S., Chen, W. L. K., Duignan, D. B., Gupta, A., Hariparsad, N., Kenny, J. R., Lai, W. G., Liras, J., Phillips, J. A., & Gan, J. (2020) · Lab on a Chip · doi:10.1039/c9lc00857h · Cited by 109
Mao, S., Gao, D., Liu, W., Wei, H., & Lin, J.-M. (2012) · Lab Chip · doi:10.1039/c1lc20678h · Cited by 101
Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro
Dash, A., Simmers, M. B., Deering, T. G., Berry, D. J., Feaver, R. E., Hastings, N. E., Pruett, T. L., LeCluyse, E. L., Blackman, B. R., & Wamhoff, B. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00331.2012 · Cited by 108
“The drug concentration used to demonstrate metabolic responses or toxicity is usually very different from corresponding in vivo plasma concentrations achieving similar effects (22, 26, 33, 41, 47).”
BackgroundRecent developments in microfluidic devices for in vitro cell culture for cell-biology research
Gao, D., Liu, H., Jiang, Y., Lin, J., Gao, D., Liu, H., & Jiang, Y. (2012) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2012.02.008 · Cited by 108
Davidson, M. D., Ballinger, K. R., & Khetani, S. R. (2016) · Scientific Reports · doi:10.1038/srep28178 · Cited by 107
Self-citationOn-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro
Jang, M., Neuzil, P., Volk, T., Manz, A., & Kleber, A. (2015) · Biomicrofluidics · doi:10.1063/1.4922863 · Cited by 95
Design of biomimetic cellular scaffolds for co-culture system and their application
Kook, Y.-M., Jeong, Y., Lee, K., & Koh, W. (2017) · Journal of Tissue Engineering · doi:10.1177/2041731417724640 · Cited by 107
The application of 3D cell models to support drug safety assessment: Opportunities & challenges
Roth, A. B., & Singer, T. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.12.005 · Cited by 105
“[64] S.R. Khetani, S.N. Bhatia, Microscale culture of human liver cells for drug development, Nat.”
Wu, Y., Wenger, A., Golzar, H., & Tang, X. (2020) · Scientific Reports · doi:10.1038/s41598-020-77146-3 · Cited by 94
Kang, Y. B. (., Rawat, S., Cirillo, J., Bouchard, M., & Noh, H. (. (2013) · Biofabrication · doi:10.1088/1758-5082/5/4/045008 · Cited by 88
“Hepatocyte functions were evaluated by monitoring urea synthesis [20, 21].”
MethodA Bioartificial Renal Tubule Device Embedding Human Renal Stem/Progenitor Cells
Sciancalepore, A. G., Sallustio, F., Girardo, S., Passione, L. G., Camposeo, A., Mele, E., Lorenzo, M. D., Costantino, V., Schena, F. P., & Pisignano, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087496 · Cited by 104
“compartments of blood vessels [14,15], liver [16,17], brain [18],”
Patterned and switchable surfaces for biomolecular manipulation
Hook, A. L., Voelcker, N. H., & Thissen, H. W. (2009) · Acta Biomaterialia · doi:10.1016/j.actbio.2009.03.040 · Cited by 103
“[93] designed a PDMS mould consisting of 300 lm thick membranes with through-holes at the bottom of each well in a 24-well layout.”
MethodLiu, Y., Li, H., Yan, S., Wei, J., & Li, X. (2014) · Biomacromolecules · doi:10.1021/bm401926k · Cited by 94
A Research Agenda for Malaria Eradication: Basic Science and Enabling Technologies
The malERA Consultative Group on Basic Science and Enabling Technologies (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1000399 · Cited by 94
Next-Generation Phenotypic Screening in Early Drug Discovery for Infectious Diseases
Aulner, N., Danckaert, A., Ihm, J., Shum, D., & Shorte, S. L. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.05.004 · Cited by 102
Sarkar, U., Rivera‐Burgos, D., Large, E. M., Hughes, D. J., Ravindra, K. C., Dyer, R. L., Ebrahimkhani, M. R., Wishnok, J. S., Griffith, L. G., & Tannenbaum, S. R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.063495 · Cited by 101
“A notable exception is the micropattern cocultures first published by Khetani and Bhatia (2006, 2008), which have been used for extensive clearance and metabolite identification studies (Wang et al., 2010; Dash et al., 2012; Chan et al., 2013).”
BackgroundBricks, T., Paullier, P., Legendre, A., Fleury, M., Zeller, P., Merlier, F., Anton, P. M., & Leclerc, É. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.02.005 · Cited by 101
Witters, D., Vergauwe, N., Vermeir, S., Ceyssens, F., Liekens, S., Puers, R., & Lammertyn, J. (2011) · Lab on a Chip · doi:10.1039/c1lc20340a · Cited by 101
Primary cells and stem cells in drug discovery: emerging tools for high-throughput screening
Eglen, R., & Reisine, T. (2011) · ASSAY and Drug Development Technologies · doi:10.1089/adt.2010.0305 · Cited by 100
“63 For example, Ca þþ signaling in primary myocytes is used to measure compound toxicity 24 (Table 4), as well as to identify novel cardioselective compounds that modulate electrical pacing activity and contractility.”
Engineered Microsystems for Spheroid and Organoid Studies
Kang, S., Kim, D., Lee, J., Takayama, S., & Park, J. Y. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001284 · Cited by 100
Song, W., Lu, Y.-C., Frankel, A. S., An, D., Schwartz, R. E., & Ma, M. (2015) · Scientific Reports · doi:10.1038/srep16884 · Cited by 92
Cowell, A. N., & Winzeler, E. A. (2019) · Genome Medicine · doi:10.1186/s13073-019-0673-3 · Cited by 99
Walker, P. A., Ryder, S., Lavado, A., Dilworth, C., & Riley, R. J. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02763-w · Cited by 90
Sancho‐Bru, P., Roelandt, P. R., Narain, N., Pauwelyn, K. A., Notelaers, T., Shimizu, T., Ott, M., & Verfaillie, C. M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.014 · Cited by 99
“Moreover, we hypothesize that assembly of iPS-derived hepatocyte-like cells with mesenchymal cells in a sinusoidal-like configuration may have a beneficial impact on cell differentiation, hepatocyte function, and ultimate engraftment in the liver after transplantation [40,41].”
BackgroundSurface Acoustic Waves Grant Superior Spatial Control of Cells Embedded in Hydrogel Fibers
Lata, J. P., Guo, F., Guo, J., Huang, P., Yang, J. H., & Huang, T. J. (2016) · Advanced Materials · doi:10.1002/adma.201602947 · Cited by 99
Microfluidic-based vascularized microphysiological systems
Lee, S., Ko, J., Park, D., Lee, S.-R., Chung, M., Lee, Y., & Jeon, N. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00285a · Cited by 91
Yamada, M., Hori, A., Sugaya, S., Yajima, Y., Utoh, R., Yamato, M., & Seki, M. (2015) · Lab on a Chip · doi:10.1039/c5lc00785b · Cited by 98
Organs-on-chip monitoring: sensors and other strategies
Kilic, T., Navaee, F., Stradolini, F., Renaud, P., & Carrara, S. (2018) · Microphysiological Systems · doi:10.21037/mps.2018.01.01 · Cited by 96
“Thanks to recent advancements in microfabrication techniques as well as 3D bioprinting (23,24), various liveron-a-chip platforms have been developed so far (25-29).”
BackgroundShedding light on 3D printing: Printing photo-crosslinkable constructs for tissue engineering
Zhang, Q., Bei, H., Zhao, M., Dong, Z., & Zhao, X. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121566 · Cited by 97
A cost-effective fluorescence mini-microscope for biomedical applications
Zhang, Y. S., Ribas, J., Nadhman, A., Aleman, J., Selimović, Š., Lesher-Perez, S. C., Wang, T., Manoharan, V., Shin, S.-R., Damilano, A., et al. (2015) · Lab on a Chip · doi:10.1039/c5lc00666j · Cited by 90
Hoshida, Y., Fuchs, B. C., & Tanabe, K. K. (2012) · Current Cancer Drug Targets · doi:10.2174/15680096112091129 · Cited by 96
Organs-on-a-chip: a union of tissue engineering and microfabrication
Zhao, Y., Wang, E. Y., Lai, F. B. L., Cheung, K., & Radisic, M. (2023) · Trends in Biotechnology · doi:10.1016/j.tibtech.2022.12.018 · Cited by 93
Grant, R., Hallett, J., Forbes, S., Hay, D., & Callanan, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-42627-7 · Cited by 90
Degradable hydrogels derived from PEG‐diacrylamide for hepatic tissue engineering
Stevens, K. R., Miller, J. S., Blakely, B. L., Chen, C. S., & Bhatia, S. N. (2015) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35478 · Cited by 82
Self-citationLee, J. B., & Sung, J. H. (2013) · Biotechnology Journal · doi:10.1002/biot.201300086 · Cited by 92
“[35] developed a liver-on-a-chip, in which the microscale architecture of the human liver tissue was reproduced by co-culturing hepatocytes and fibroblasts in precisely defined areas.”
BackgroundThree-dimensional perfused cell culture
Li, Z., & Cui, Z. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.10.006 · Cited by 92
“The cellular communications can also be studied using 2D culture but on naturally derived ECM-coated surfaces, ormicropatterned surfaces (Kane et al., 1999; Khetani and Bhatia, 2008; Liu and Chen, 2007; Mitragotri and Lahann, 2009).”
BackgroundChen, A. A., Khetani, S. R., Lee, S., Bhatia, S. N., & Van Vliet, K. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.10.055 · Cited by 88
“The authors verified the previously reported and well-known ‘‘co-culture effect’’ on their surfaces by showing that 3T3 murine embryonic fibroblasts were able to induce functions in primary rat hepatocytes via heterotypic signaling [16,32,33].”
BackgroundSelf-citationMatsuzawa, A., Matsusaki, M., & Akashi, M. (2012) · Langmuir · doi:10.1021/la303459v · Cited by 92
Recent lab‐on‐chip developments for novel drug discovery
Khalid, N., Kobayashi, I., & Nakajima, M. (2017) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1381 · Cited by 83
An update on metabolism studies using human hepatocytes in primary culture
Gómez-Lechón, M. J., Castell, J. V., & Donato, M. T. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.7.837 · Cited by 80
“A miniaturized, multi-well culture system for human liver cells with optimized microscale architecture that maintains phenotypic functions for several weeks has been recently reported [148] .”
BackgroundConsidering new methodologies in strategies for safety assessment of foods and food ingredients
Blaauboer, B. J., Boobis, A. R., Bradford, B., Cockburn, A., Constable, A., Daneshian, M., Edwards, G., Garthoff, J. A., Jeffery, B., Krul, C. A. M., et al. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.02.019 · Cited by 91
“It could also be shown, that the culturing of primary hepatocytes (clusters) on micro-patterned spots surrounded by fibroblasts will lead to preservation of hepatic functions for a significant longer period (Khetani and Bhatia, 2008).”
BackgroundSiltanen, C. A., Diakatou, M., Lowen, J. M., Haque, A., Rahimian, A., Stybayeva, G., & Revzin, A. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.010 · Cited by 91
“[38] However, collecting purified hepatocytes from these cocultures for downstream analysis or application can be somewhat challenging.”
BackgroundEngineered Liver Platforms for Different Phases of Drug Development
Ware, B. R., & Khetani, S. R. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.001 · Cited by 90
“PHHs displayed CYP450 activities for ~3 months, while the NPCs expressed prototypical markers [33].”
MethodInfluentialSelf-citationCarpentier, A., Nimgaonkar, I., Chu, V., Xia, Y., Hu, Z., & Liang, T. J. (2016) · Stem Cell Research · doi:10.1016/j.scr.2016.03.009 · Cited by 90
“Furthermore the HLCs tend to lose their differentiated phenotypewith timewithout special culturing condition (Khetani and Bhatia, 2008).”
BackgroundUsta, O. B., McCarty, W. J., Bale, S., Hegde, M., Jindal, R., Bhushan, A., Golberg, I., & Yarmush, M. L. (2015) · TECHNOLOGY · doi:10.1142/s2339547815300012 · Cited by 85
Pettinato, G., Ramanathan, R., Fisher, R. A., Mangino, M. J., Zhang, N., & Wen, X. (2016) · Scientific Reports · doi:10.1038/srep32888 · Cited by 90
Innovations in 3D Tissue Models of Human Brain Physiology and Diseases
Lovett, M. L., Nieland, T. J. F., Dingle, Y. L., & Kaplan, D. L. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909146 · Cited by 90
Lan, S.-F., & Starly, B. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.07.013 · Cited by 90
Engineered tissues and strategies to overcome challenges in drug development
Khalil, A. S., Jaenisch, R., & Mooney, D. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.09.012 · Cited by 89
3D in vitro tissue models and their potential for drug screening
Kimlin, L., Kassis, J., & Virador, V. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.852181 · Cited by 79
“Biomarkers related to cell-cell interaction, such as ICAMs, can also serve as surrogate endpoints to predict toxicity in 3D cultures [73].”
BackgroundAvior, Y., Levy, G., Zimerman, M., Kitsberg, D., Schwartz, R., Sadeh, R., Moussaieff, A., Cohen, M., Itskovitz‐Eldor, J., & Nahmias, Y. (2015) · Hepatology · doi:10.1002/hep.27803 · Cited by 88
“Epithelial polarization is a critical function of hepatocytes, which secrete bile acids and modified drug metabolites by apical bile canaliculi.(9,10) By day 16 of differentiation, in the presence of LCA and MK4, cells acquired homogenous cuboidal morphology and displayed granular perinuclear staining for albumin and…”
BackgroundChong, S., Smith, A. A. A., & Zelikin, A. N. (2013) · Small · doi:10.1002/smll.201201774 · Cited by 88
Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis
Hurrell, T., Kastrinou-Lampou, V., Fardellas, A., Hendriks, D. F. G., Nordling, Å., Johansson, I., Baze, A., Parmentier, C., Richert, L., & Ingelman-Sundberg, M. (2020) · Cells · doi:10.3390/cells9040964 · Cited by 82
Rebelo, S. P., Costa, R., Silva, M. M., Marcelino, P., Brito, C., & Alves, P. M. (2017) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2099 · Cited by 77
“…role of the stroma in the maintenance of differentiated hepatocytic phenotype by co-culturing hepatocytes with nonparenchymal liver cells, such as liver sinusoidal endothelial cells (LSECs), stellate, Kupffer and other non-hepatic cellular types (Khetani and Bhatia, 2008; Kostadinova et al., 2013).”
BackgroundMicro- and nanoengineering for stem cell biology: the promise with a caution
Kshitiz, Kim, D.-H., Beebe, D. J., & Levchenko, A. (2011) · Trends in Biotechnology · doi:10.1016/j.tibtech.2011.03.006 · Cited by 81
Engineered Human Contractile Myofiber Sheets as a Platform for Studies of Skeletal Muscle Physiology
Takahashi, H., Shimizu, T., & Okano, T. (2018) · Scientific Reports · doi:10.1038/s41598-018-32163-1 · Cited by 86
Substrate stiffness regulates primary hepatocyte functions
Natarajan, V., Berglund, E. J., Chen, D. X., & Kidambi, S. (2015) · RSC Advances · doi:10.1039/c5ra15208a · Cited by 84
Microscale screening systems for 3D cellular microenvironments: platforms, advances, and challenges
Montanez-Sauri, S. I., Beebe, D. J., & Sung, K. E. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1738-5 · Cited by 80
“For instance, human liver cells and epithelial cells were previously cultured on collagen type I and Matrigel microarrays, respectively [44, 45].”
Vunjak-Novakovic, G., Bhatia, S., Chen, C., & Hirschi, K. (2013) · Stem Cell Research & Therapy · doi:10.1186/scrt369 · Cited by 80
“Summary of current progress Representative results for the fi rst project year are summarized in Figures 1 and 2, and in several publications [8,10,12-27].”
BackgroundSelf-citationZhou, Y., Shen, J. X., & Lauschke, V. M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01093 · Cited by 85
Prediction of Drug Clearance and Drug-Drug Interactions in Microscale Cultures of Human Hepatocytes
Lin, C., Shi, J., Moore, A., & Khetani, S. R. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066027 · Cited by 84
“observed in freshly isolated PHHs (Lecluyse, 2001; Khetani and Bhatia, 2008).”
BackgroundMethodInfluentialSelf-citationMagnetic manipulation and spatial patterning of multi-cellular stem cell aggregates
Bratt-Leal, A. M., Kepple, K. L., Carpenedo, R. L., Cooke, M. T., & McDevitt, T. C. (2011) · Integrative Biology · doi:10.1039/c1ib00064k · Cited by 73
Alginate gel microwell arrays using electrodeposition for three-dimensional cell culture
Ozawa, F., Ino, K., Arai, T., Ramón‐Azcón, J., Takahashi, Y., Shiku, H., & Matsue, T. (2013) · Lab on a Chip · doi:10.1039/c3lc50455g · Cited by 84
Moreno-Jiménez, I., Kanczler, J. M., Hulsart‐Billström, G., Inglis, S., & Oreffo, R. O. C. (2017) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2017.0186 · Cited by 84
“13 15 In the meantime, the in vitro culture of organs (organo-typic culture/organoids) provides a closer biological approach to in vivo physiology while minimizing the need to conduct procedures on living animals.”
Devarasetty, M., Mazzocchi, A. R., & Skardal, A. (2018) · BioDrugs · doi:10.1007/s40259-017-0258-x · Cited by 75
“The addition of fibroblasts increased the duration and magnitude of hepatocyte function as measured by mitochondrial metabolism and cytochrome p450 (CYP) activity, demonstrating the importance of cell–cell interaction and the incorporation of a stromal component for physiologic liver function [33].”
InfluentialLiver Tissue Engineering: Challenges and Opportunities
Agarwal, T., Subramanian, B., & Maiti, T. K. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00745 · Cited by 83
Gori, M., Giannitelli, S. M., Torre, M., Mozetic, P., Abbruzzese, F., Trombetta, M., Traversa, E., Moroni, L., & Rainer, A. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001163 · Cited by 76
Messner, S., Fredriksson, L., Lauschke, V. M., Roessger, K., Escher, C., Bober, M., Kelm, J. M., Ingelman-Sundberg, M., & Moritz, W. (2018) · Applied In Vitro Toxicology · doi:10.1089/aivt.2017.0022 · Cited by 72
Smith, E. M., & Wilson, J. Y. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.01.005 · Cited by 82
In vitro microscale systems for systematic drug toxicity study
Sung, J. H., & Shuler, M. L. (2009) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-009-0369-y · Cited by 82
“Authenticity of cell function Cells cultured in vitro often display cell functions different from their native environment Co-culture with supporting cells [ 87 , 92]”
BackgroundMethodInfluentialLerapetritou, M. G., Georgopoulos, P. G., Roth, C. M., & Androulakis, L. P. (2009) · Clinical and Translational Science · doi:10.1111/j.1752-8062.2009.00092.x · Cited by 77
van Noort, D., Ong, S. M., Zhang, C., Zhang, S., Arooz, T., & Yu, H. (2009) · Biotechnology Progress · doi:10.1002/btpr.171 · Cited by 73
“…cocultured with other cell types in adjacent microregions to study the effects of cell–cell interaction and exchange of soluble factors between cell types (Bhatia et al., 1997, 1998, 1999; Hui and Bhatia, 2007; Khatani and Bhatia, 2008; Zinchenko and Coger, 2005; Zinchenko et al., 2006a, 2006b).”
BackgroundMimicking Human Pathophysiology in Organ‐on‐Chip Devices
Yeşil-Çeliktaş, Ö., Hassan, S., Miri, A. K., Maharjan, S., Al‐kharboosh, R., Quiñones‐Hinojosa, A., & Zhang, Y. S. (2018) · Advanced Biosystems · doi:10.1002/adbi.201800109 · Cited by 81
Zhang, J., Jin, Z., Hu, X., Meng, H., Li, J., Zhang, X., Liu, H., Deng, T., Yao, S., & Feng, L. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01659 · Cited by 80
Deegan, D. B., Zimmerman, C., Skardal, A., Atala, A., & Shupe, T. D. (2016) · Journal of the Mechanical Behavior of Biomedical Materials · doi:10.1016/j.jmbbm.2015.10.016 · Cited by 79
Kikuchi, K., Sumaru, K., Edahiro, J., Ooshima, Y., Sugiura, S., Takagi, T., & Kanamori, T. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22253 · Cited by 79
Sonntag, F., Schilling, N., Mader, K., Gruchow, M., Klotzbach, U., Lindner, G., Horland, R., Wagner, I. P., Lauster, R., Howitz, S., et al. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.02.001 · Cited by 79
Yen, C.-M., Chan, C., & Lin, S. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.02.014 · Cited by 78
Deng, J., Zhang, X., Chen, Z., Luo, Y., Lu, Y., Liu, T., Wu, Z., Jin, Y., Zhao, W., & Lin, B. (2019) · Biomicrofluidics · doi:10.1063/1.5070088 · Cited by 70
Metadata
- Authors
- Khetani, S. R., & Bhatia, S. N.
- Affiliations
- Massachusetts Institute of Technology (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Bhatia, Sangeeta N
- Venue
- Nature Biotechnology
- Published
- 2007-11-18
- Volume
- 26
- Issue
- 1
- Pages
- 120-126
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2023296392
- Cited by
- 1,219
- References
- 41
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 36 · 2023: 49 · 2022: 64 · 2021: 56 · 2020: 68 · 2019: 73 · 2018: 81 · 2017: 86 · 2016: 93 · 2015: 77 · 2014: 76 · 2013: 90 · 2012: 75
- FWCI
- 38.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- human liver cells, liver-on-a-chip, hepatotoxicity, drug development, phase I and II metabolism, canalicular transport, hepatocyte secretion, gene expression profiling, tissue engineering, microtechnology
- MeSH terms
- Biological Assay, Cells, Cultured, Equipment Design, Humans, Miniaturization, Drug Design, Flow Injection Analysis, Cell Culture Techniques, Equipment Failure Analysis, Hepatocytes, Microfluidic Analytical Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.